Google Alert - hepatitis c

[Guest guest]

News

10 new results for hepatitis c

Merck aims at hepatitis, c. difficile drugsReutersÊ By Ransdell Pierson NEW YORK (Reuters) - The head of infectious diseases at Merck & Co said the company's future all-oral treatments for hepatitis C and its experimental drug for infections with clostridium difficile bacteria could transform ...See all stories on this topic »

Reuters

Tailored Hepatitis C Therapy May Cut Treatment Time in HalfU.S. News & World Report14 (HealthDay News) -- Patients infected with hepatitis C virus who have an early favorable response to a new three-drug regimen can be cured of the disease in half the normal time, a new study says. In the multinational study, researchers showed that ...See all stories on this topic »

Reduced Treatment Time Noninferior for Some With Hep CDoctors LoungeSustained virologic response for some patients who have chronic hepatitis C virus was found to be noninferior when treating for 24 weeks versus 48 weeks, according to a study published in the Sept. 15 issue of the New England Journal of Medicine. ...See all stories on this topic »

Genotyping HCV Patients for HLA-C and IL28B Improves Ability to Predict ...Genetic Engineering NewsThe International Hepatitis C Genetics Consortium (IHCGC) genotyped over 1000 chronic hepatitis C (CHC) patients of European descent, to evaluate whether they were HLA-C C1 or C2 carriers and for the presence of inhibitory and activating KIR genes, ...See all stories on this topic »

Hope for effective vaccine against hepatitis C!Indian ExpressIn what may pave the way for an effective vaccine and treatment against the potentially fatal hepatitis C infection, scientists claim to have discovered two “Achilles' heels†within the virus. Hepatitis C virus infection is a global pandemic with more ...See all stories on this topic »

Coffee consumption reduces side-effects in people on hepatitis C treatmentaidsmapDrinking three or more cups of coffee a day reduced the incidence of self-reported side effects by more than 80% compared to non-coffee drinkers in people co-infected with hepatitis C and HIV who were taking hepatitis C treatment, a French study has ...See all stories on this topic »

Tailored Hepatitis C Therapy May Cut Treatment Time in HalfNewsday (subscription)Click here Tailored Hepatitis C Therapy May Cut Treatment Time in Half Published: September 14, 2011 5:06 PM from By Madonna Behen HealthDay Reporter Patients infected with hepatitis C virus who have an early favorable response to a new three-drug ...See all stories on this topic »

Newsday (subscription)

OBN's 2011 Annual Awards Dinner Celebrates UK Bioscience Success StoriesSacramento BeeIncivek™ (telaprevir) is a new oral medicine approved in the USA in May 2011 for the treatment of hepatitis C. It acts directly on the hepatitis C virus protease, an enzyme essential for viral replication. In clinical trials, Incivek has been shown to ...See all stories on this topic »

Idenix Pharmaceuticals Shares Climbing Higher, Up 2.3%Financial News Network OnlineThe Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV). In the past 52 weeks, shares of Idenix Pharmaceuticals have traded between a low of $2.57 and a high of $7.05 ...See all stories on this topic »

The FDA's Dr. Lawrence Deyton on the tests of leadershipWashington Post (blog)... the Department of Veterans Affairs (VA) where he was chief public health officer and oversaw VA programs aimed at HIV, hepatitis C, bioterrorism, military environmental exposure, women veterans health tobacco use and employee occupational health. ...See all stories on this topic »